Oxford Immunotec

Commercial-stage diagnostics company using immune markers to diagnose disease

placeAbingdon, England, United Kingdom calendar_todayFounded 2002 groups184 employees language oxfordimmunotec.com

Registered entities

Innovation

21 patent families (8 granted) — focus: Physics & computing, Chemistry & metallurgy, Operations & transport; filing pace slowing. Cited 568 times.

YearFilings
20121
20131
20152
20163
20172
20192
20201
20217
20225
20231
20241
20261

Investor mix

14 investors on record; lead investors include New Leaf Venture Partners, Kaiser Permanente Ventures, Spark Ventures, Draper Esprit.

Investor typeCountShare
Venture capital750%
Private equity214%
Accelerator & incubator214%
Other / undisclosed321%
Coming soon